Life Tech, RainTree Oncology Announce Collaboration
Life Technologies Corporation (NASDAQ: LIFE) and RainTree Oncology Services today announced they have entered into a collaboration agreement designed to further the advancement of personalized care for cancer patients.
Through the collaboration, RainTree and Life Technologies will seek to make the latest advances in molecular testing available to the broader patient market and will work to develop a streamlined protocol for entering patients into clinical trials for new targeted therapies.
Key elements of the collaboration are:
o Collaborate on matching oncology patients to clinical trials using a Next Generation Sequencing Oncology screening panel; o Develop a clinical trials recruitment database which incorporates RainTree's broad patient data set, enhanced by other data sources, including Life's Compendia analytics engine; o Educate private payors and health plans about the benefits of Next Generation Sequencing; and o Build and market comprehensive product, test and data offerings for clinical research organizations.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.